Oncology

With a proven track record in oncology, the organization is now expanding its expertise into the dermatology sector. Building on its success in in-house API manufacturing, the team aims to bring the same level of innovation and quality to the derma space. By leveraging backward integration and strong R&D capabilities, they are poised to introduce a range of new treatments that address unmet needs in both oncology and dermatology. This strategic diversification highlights their commitment to broadening their therapeutic portfolio while maintaining leadership in key areas of healthcare.